• Eva-Lotta Allan’s excellent track record of corporate, business development and operational experience strengthens industry-leading Board and Executive Leadership team
• Maxion’s lead KnotBody® programme is progressing rapidly towards preclinical development with a first-in-class and best-in-class potential
News
Unlock a 25% discount today on all OGM services with Source Genomics, limited time only.
OGM is introducing a new dimension to genomic analysis, taking a high-resolution snapshot of genome structure in its entirety, including structural variants and large-scale re-arrangements.
Anglia Ruskin University has been shortlisted for the University of the Year award in this year’s Times Higher Education (THE) Awards, widely known as the Oscars of the UK university sector. They are also shortlisted for the Outstanding Contribution to the Local Community award (for the creation of ARU Peterborough) and Outstanding Contribution to Equality, Diversity and Inclusion award (for our SHoKE project).
In their latest podcast, Optimum Stategic Communications dicuss the hot areas for investment in the shifting biotech market - including antibody-drug conjugates, smart radiotherapies, mRNA and immune-oncology.
Webinar will present practical strategies to achieve definitive results when researching unstable, sticky, or insoluble compounds
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, is hosting a webinar entitled “Uncooperative Drugs in In Vitro Transporter Research: Practical Approaches to Address Instability and Nonspecific Binding Challenges” at 11 am ET on September 20.
- Funds to support further development and commercialization of the Company’s INDUCE-seq DNA break mapping technology
- Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression of cell and gene therapy programs
- New investors include Illumina Ventures, Mérieux Equity Partners, and HERAN Partners
Recognising that research and development and production of medicines requires a significant amount of energy, AstraZeneca recently shared an article on 'Powering emissions reductions with clean heat and renewable energy' explaining how they are working toward net zero goals through innovative partnerships.
"The addition of the 1.25 millionth structure to the CSD is a great achievement for the community. Being the world’s largest database of small-molecule organic and metal-organic crystal structure data, the CSD is used in over 70 countries by scientists and crystallographers working both in academia and in pharmaceutical companies. Each of the structures deposited by scientists from around the globe is curated by our expert scientific editors prior to entry in the database.
After five years of leading LifeArc, Dr. Melanie Lee has informed the Board of her decision to step down as Chief Executive Officer.
We extend an invitation to explore our latest article titled "Powering Regional Growth: The Cambridge Cluster” penned by our CEO, Sunil Shah. The recent article which has been published by Intelligent Partnership delves into various facets of the biotech ecosystem, including insights on the golden triangle and tax-efficient investment strategies.
Should you find this content valuable, we would request you to share it with your professional network.